What amount sold does Zephyr AI, Inc. report in Form D filings?

The latest linked filings report $129.7M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Zephyr AI, Inc.'s most recent SEC filing?

Zephyr AI, Inc.'s most recent Form D filing was on 2024-03-13.

How many investors does Zephyr AI, Inc. have?

The most recent Form D filing lists 30 investor(s).

What type of securities does Zephyr AI, Inc. offer?

Zephyr AI, Inc.'s SEC Form D filings indicate equity offerings.

Zephyr AI, Inc.

CIK: 0001915384·Biotechnology·McLean, VA·Corporation·Founded 2021

Reported Sold

$129,714,276

Total Filings

Identified Offerings

Last Filed

Mar 13, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 13, 2024Form D — New notice

Reported sold: $111,354,487 · Target: $120,663,249

Rule 506(b)·30 investors

Apr 4, 2022Form D — New notice

Reported sold: $18,359,789 · Target: $19,734,816

Rule 506(b)·31 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$129,714,276

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Roger Ferguson

Related Person

Appears on 1 filing

Rob Myers

Related Person

Appears on 1 filing

Yisroel Brumer

Related Person

Appears on 1 filing

Jack Rowe

Related Person

Appears on 1 filing

Sol Barer

Related Person

Appears on 1 filing

Ken Samet

Related Person

Appears on 1 filing

Jeff Sherman

Related Person

Appears on 1 filing

Grant Verstandig

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 13, 2024	New	$120,663,249	$111,354,487	30
Apr 4, 2022	New	$19,734,816	$18,359,789	31

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Contraline, Inc.

Biotechnology

Offering target: $115,929,658

Filed Jun 10, 2026